Healthcare: Gen AI speeds up workflows, drug development – ET HealthWorld

Healthcare: Gen AI speeds up workflows, drug development – ET HealthWorld

New Delhi: There are people who have to wait for days, weeks, and months for a complex surgery because it needs prior authorisation from insurance payers. This authorisation involves the review of lots of clinical and insurance policy documents to check whether the procedure is necessary and whether the insurance plan will pay for it. … Read more

Research: AI tailors artificial DNA for future drug development – ET HealthWorld

Research: AI tailors artificial DNA for future drug development – ET HealthWorld

Washington: With the help of AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to the development and production of vaccines, drugs for severe diseases, as well as alternative food proteins much faster and at significantly lower costs than today. … Read more

Artificial Intelligence – a game changer in revolutionizing drug discovery – ET HealthWorld

Artificial Intelligence – a game changer in revolutionizing drug discovery – ET HealthWorld

By Dr Mahesh Bhalgat Artificial intelligence (AI) presents the possibility to alter the drug discovery process and has grown significantly, in the past few years. Over 150 companies have applied AI-based drug discovery approaches to raise funds and progress molecules into clinical trials. Before diving into the use of Artificial Intelligence in drug discovery, a … Read more

Supercomputers Mimic Brain Activity, Hunt for COVID Treatments

Oct. 15, 2021 — Machine learning has come a long way in the quarter-century since a computer nicknamed Deep Blue shocked the world by beating chess champion Garry Kasparov. Today, when our smartphones have far more computing power than Deep Blue, scientists have trained their sights on even bigger opponents, including potentially fatal illnesses like … Read more

U.S. Science Labs Getting Towering New Equipment

Aug. 3, 2021 — To reach the summit of two multimillion-dollar pieces of state-of-the-art equipment, scientists climb stairways spiraling around the structures — each the size of two supersized stacked refrigerators. The $40 million National Science Foundation investment is intended, in part, to advance health research and drug development. The spectrometers operate in … Read more

Paving the Way for Diversity in Clinical Trials

Hala Borno, MD, assistant professor of medicine, Division of Oncology and Hematology, University of California, San Francisco Jamie Freedman, head of U.S. medical affairs, Genentech. Jennifer Jones-McMeans, PhD, director of global clinical affairs, Abbott Pharmaceuticals. Marya Shegog, PhD, health equity and diversity coordinator, Lazarex Cancer Foundation. Andrea Denicoff, registered nurse and nurse consultant, National Cancer … Read more

Immunotherapy Drug Helping Lung Cancer Patients

By Robert Preidt HealthDay Reporter THURSDAY, Oct. 1, 2020 (HealthDay News) — A newly approved drug for the leading form of the number one cancer killer, lung cancer, does improve patient survival, a new study confirms. The immunotherapy drug Tecentriq (atezolizumab) was approved earlier this year by the U.S. Food and Drug Administration … Read more